Correlation Between Dyadic International and Theriva Biologics
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Theriva Biologics, you can compare the effects of market volatilities on Dyadic International and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Theriva Biologics.
Diversification Opportunities for Dyadic International and Theriva Biologics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dyadic and Theriva is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of Dyadic International i.e., Dyadic International and Theriva Biologics go up and down completely randomly.
Pair Corralation between Dyadic International and Theriva Biologics
Given the investment horizon of 90 days Dyadic International is expected to generate 1.98 times more return on investment than Theriva Biologics. However, Dyadic International is 1.98 times more volatile than Theriva Biologics. It trades about 0.18 of its potential returns per unit of risk. Theriva Biologics is currently generating about -0.05 per unit of risk. If you would invest 117.00 in Dyadic International on September 17, 2024 and sell it today you would earn a total of 32.00 from holding Dyadic International or generate 27.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Dyadic International vs. Theriva Biologics
Performance |
Timeline |
Dyadic International |
Theriva Biologics |
Dyadic International and Theriva Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Theriva Biologics
The main advantage of trading using opposite Dyadic International and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.Dyadic International vs. Puma Biotechnology | Dyadic International vs. Iovance Biotherapeutics | Dyadic International vs. Zentalis Pharmaceuticals Llc | Dyadic International vs. Syndax Pharmaceuticals |
Theriva Biologics vs. Puma Biotechnology | Theriva Biologics vs. Iovance Biotherapeutics | Theriva Biologics vs. Zentalis Pharmaceuticals Llc | Theriva Biologics vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |